Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  satraplatin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-15 of 15 for your search:
Start Over
Phase III Randomized Study of BMS-182751 Plus Prednisone versus Prednisone Alone in Patients with Symptomatic Hormone-Refractory Prostate Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: BMS-CA142-029
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GPC SAT3-03-01, NCT00069745
Phase II Study of Oral BMS-182751 (a Platinum Compound) for Nonsmall Cell Lung Cancer (Summary Last Modified 07/95)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-16942N
Phase II Study of BMS-182751 for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix (Summary Last Modified 07/1999)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAN-NCIC-IND102, BMS-182751, IND102
Satraplatin for Patients With Metastatic Breast Cancer (MBC)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: Protocol 05-021, NCT00265655
Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SAT2-05-05, NCT00268970
A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 70 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SAT2-05-07, NCT00370383
Satraplatin and Prednisone to Treat Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 080074, 08-C-0074, NCI-08-C-0074, NCI-P07140, NCT00634647
Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: GCO 10-1222, Prostate Cancer Foundation, NCT01289067
Phase I Study of Oral BMS-182751 (a Platinum Analogue) and VP-16 in Previously Untreated Advanced Cancer Including Extensive Stage SCLC (Summary Last Modified 01/95)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND85, NCI-V94-0557, IND85
Phase I Study of BMS-182751 (a Platinum Compound) plus Etoposide in Advanced Nonhematologic Malignancies (Summary Last Modified 04/2000)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAN-NCIC-IND96, BMS-CA142-016, BMS-CAN-NCIC-IND96, NCI-V96-1065, IND96
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 0606001535, NCT00473720
Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 3 to 21
Sponsor: NCI
Protocol IDs: 110047, 11-C-0047, NCT01259479
Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000518085, P30CA022453, WSU-2006-118, NCT00499694
Start Over